Therapeutic Area | MeSH |
---|---|
respiratory tract diseases | D012140 |
cardiovascular diseases | D002318 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
INNOHEP | LEO Pharma | N-020484 DISCN | 2000-07-14 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
innohep | 2008-04-14 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
venous thrombosis | HP_0004936 | D020246 | I82.40 |
pulmonary embolism | HP_0002204 | D011655 | I26 |
thromboembolism | HP_0001907 | D013923 | — |
Code | Description |
---|---|
J1655 | Injection, tinzaparin sodium, 1000 iu |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Thromboembolism | D013923 | HP_0001907 | — | 2 | 14 | 53 | 28 | 60 | 153 |
Thrombosis | D013927 | — | — | 3 | 16 | 35 | 29 | 57 | 135 |
Venous thromboembolism | D054556 | EFO_0004286 | I74 | 2 | 11 | 38 | 21 | 51 | 120 |
Venous thrombosis | D020246 | HP_0004936 | I82.40 | — | 11 | 26 | 22 | 34 | 90 |
Embolism | D004617 | — | — | 1 | 3 | 18 | 20 | 20 | 61 |
Covid-19 | D000086382 | — | — | 1 | 13 | 16 | 7 | 25 | 59 |
Pulmonary embolism | D011655 | HP_0002204 | I26 | 1 | 2 | 17 | 20 | 20 | 59 |
Neoplasms | D009369 | — | C80 | 1 | 5 | 11 | 3 | 16 | 35 |
Syndrome | D013577 | — | — | 4 | 7 | 7 | 5 | 5 | 26 |
Hemorrhage | D006470 | MP_0001914 | R58 | 1 | 1 | 3 | 4 | 10 | 19 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple myeloma | D009101 | — | C90.0 | 2 | 4 | 2 | — | 4 | 11 |
Plasma cell neoplasms | D054219 | — | — | 2 | 4 | 2 | — | 4 | 11 |
Colorectal neoplasms | D015179 | — | — | — | 1 | 4 | — | 2 | 7 |
Blood coagulation disorders | D001778 | EFO_0009314 | D68.9 | 1 | — | 3 | — | 3 | 7 |
Hemostatic disorders | D020141 | — | — | 1 | — | 3 | — | 3 | 7 |
Intracranial thrombosis | D020767 | — | — | — | 2 | 3 | — | 1 | 5 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | 2 | 1 | — | 1 | 4 |
Lymphoma | D008223 | — | C85.9 | — | 2 | 1 | — | 1 | 4 |
Viral pneumonia | D011024 | EFO_0007541 | J12.9 | — | — | 2 | — | 2 | 4 |
Pre-eclampsia | D011225 | EFO_0000668 | O14 | — | 1 | 3 | — | 1 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Obesity | D009765 | EFO_0001073 | E66.9 | — | 1 | — | — | 3 | 4 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 2 | — | — | 1 | 3 |
Cytokine release syndrome | D000080424 | — | D89.83 | — | 1 | — | — | 1 | 2 |
Iga vasculitis | D011695 | EFO_1000965 | D69.0 | 1 | 1 | — | — | 1 | 2 |
Purpura | D011693 | HP_0000979 | D69.2 | 1 | 1 | — | — | 1 | 2 |
Percutaneous coronary intervention | D062645 | — | — | — | 1 | — | — | 1 | 2 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | 2 | 1 | — | — | — | 2 |
Ovarian epithelial carcinoma | D000077216 | — | — | — | 2 | — | — | — | 2 |
Spinal cord injuries | D013119 | EFO_1001919 | — | — | 1 | — | — | — | 1 |
Duodenal neoplasms | D004379 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 6 | — | — | — | — | 6 |
Pregnancy rate | D018873 | — | — | 1 | — | — | — | 1 | 2 |
Blood platelet disorders | D001791 | — | — | 1 | — | — | — | — | 1 |
Balloon angioplasty coronary | D015906 | EFO_0003951 | — | 1 | — | — | — | — | 1 |
Stillbirth | D050497 | — | P95 | 1 | — | — | — | — | 1 |
Clear cell sarcoma | D018227 | — | — | 1 | — | — | — | — | 1 |
Pseudotumor cerebri | D011559 | EFO_1001132 | G93.2 | 1 | — | — | — | — | 1 |
Intracranial hypertension | D019586 | EFO_1000992 | — | 1 | — | — | — | — | 1 |
Systemic lupus erythematosus | D008180 | HP_0002725 | M32 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Postoperative complications | D011183 | — | — | — | — | — | — | 4 | 4 |
Pain | D010146 | EFO_0003843 | R52 | — | — | — | — | 4 | 4 |
Heart valve diseases | D006349 | EFO_0009551 | I08 | — | — | — | — | 2 | 2 |
Length of stay | D007902 | — | — | — | — | — | — | 2 | 2 |
Connective tissue diseases | D003240 | EFO_1001986 | M35 | — | — | — | — | 2 | 2 |
Blood coagulation | D001777 | GO_0007596 | — | — | — | — | — | 2 | 2 |
Fertilization in vitro | D005307 | — | — | — | — | — | — | 2 | 2 |
Esophageal and gastric varices | D004932 | EFO_0009545 | I85 | — | — | — | — | 2 | 2 |
Ecchymosis | D004438 | HP_0000978 | — | — | — | — | — | 2 | 2 |
Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | — | — | 2 | 2 |
Drug common name | Tinzaparin sodium |
INN | tinzaparin sodium |
Description | Tinzaparin is an antithrombotic drug in the heparin group. It is a low molecular weight heparin (LMWH) marketed as Innohep worldwide. It has been approved by the U.S. Food and Drug Administration (FDA) for once daily treatment and prophylaxis of deep vein thrombosis (DVT) and pulmonary embolism (PE).
|
Classification | Peptide |
Drug class | heparin derivatives and low molecular weight (or depolymerized) heparins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1201414 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 3S182ET3UA (ChemIDplus, GSRS) |